Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0000921895-26-000895

Director sold 3,750,000 shares at $16.79 ($62,962,500)

From the SEC's structured data for this filing

Trades in this filing

BVF PARTNERS L P/IL · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-31 Sale : show line 1 in the form −1,932,354 $16.79 $32,444,224 8,302,735 D
2026-03-31 Sale : show line 2 in the form −1,569,116 $16.79 $26,345,458 6,599,722 D
2026-03-31 Sale : show line 3 in the form −248,530 $16.79 $4,172,819 1,039,238 D
Open-market sales · 3,750,000 sh · avg $16.79 · $62,962,500
Loading xslF345X06/form407422mltx_04022026.xml…